Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Pueraria Mirifica and Reduced Vaginal Dryness

Doses used in studies

mg/day: 20–50 (median 35, IQR 20–50) — 1 study

Time to effect

Median: 5.6 months · IQR 5.6 months–5.6 months · Range 5.6 months–5.6 months — Reported in 1 of 2 studies

Safety in these studies

Overall tolerabilityNo significant difference
There was no significant difference of adverse effects between the Pueraria mirifica and placebo groups in this study.
from: Effect of Pueraria mirifica on vaginal health.

2 of 2 papersPopulation:

Effect of Pueraria mirifica on vaginal health.
- 2007-09
- RCT · n = 71
- Menopause (New York, N.Y.) 14(5)
- - Jittima Manonai
  - Apichart Chittacharoen
  - Urusa Theppisai
  - Hathai Theppisai
- PubMed: 17415017
- DOI: 10.1097/gme.0b013e3180399486
2 Insights on
- Reduced Vaginal Dryness
- High evidence
- Adults
The mean vaginal dryness symptom in the Pueraria mirifica group decreased after 12 weeks of treatment.
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
20, 30, or 50 mg/day
An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women.
- 2019-02-20
- Review
- Post reproductive health 25(1)
- - Fatemeh R Dizavandi
  - Masoumeh Ghazanfarpour
  - Nasibeh Roozbeh
  - Leila Kargarfard
  - Talat Khadivzadeh
  - Sareh Dashti
- PubMed: 30786797
- DOI: 10.1177/2053369118823365
11 Insights on
- Reduced Vaginal Dryness
- Low evidence
- Clinical
Similar efficacy was found in Pueraria mirifica and conjugated estrogen cream on dryness (p = 0.277)
Effect
Neutral
Effect size
Small
Significant
No
Dose
not specified